1. Academic Validation
  2. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

  • Nat Med. 2007 Nov;13(11):1308-15. doi: 10.1038/nm1660.
Markus Weckmann 1 Adam Collison Jodie L Simpson Matthias V Kopp Peter A B Wark Mark J Smyth Hideo Yagita Klaus I Matthaei Nicole Hansbro Bruce Whitehead Peter G Gibson Paul S Foster Joerg Mattes
Affiliations

Affiliation

  • 1 Department of Paediatrics and Adolescent Medicine, Albert Ludwigs University Freiburg, 79106 Freiburg, Germany.
Abstract

The role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in immune responses mediated by T-helper 2 (T(H)2) lymphocytes is unknown. Here we characterize the development of allergic airway disease in TRAIL-deficient (Tnfsf10(-/-)) mice and in mice exposed to short interfering RNA targeting TRAIL. We show that TRAIL is abundantly expressed in the airway epithelium of allergic mice and that inhibition of signaling impairs production of the chemokine CCL20 and homing of myeloid dendritic cells and T cells expressing CCR6 and CD4 to the airways. Attenuated homing limits T(H)2 cytokine release, inflammation, airway hyperreactivity and expression of the transcriptional activator STAT6. Activation of STAT6 by interleukin-13 restores airway hyperreactivity in Tnfsf10(-/-) mice. Recombinant TRAIL induces pathognomic features of asthma and stimulates the production of CCL20 in primary human bronchial epithelium cells. TRAIL is also increased in sputum of asthmatics. The function of TRAIL in the airway epithelium identifies this molecule as a target for the treatment of asthma.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》